OA09027A - Procédé d'inhibition. d'un virus - Google Patents

Procédé d'inhibition. d'un virus

Info

Publication number
OA09027A
OA09027A OA59495A OA59495A OA09027A OA 09027 A OA09027 A OA 09027A OA 59495 A OA59495 A OA 59495A OA 59495 A OA59495 A OA 59495A OA 09027 A OA09027 A OA 09027A
Authority
OA
OAPI
Prior art keywords
virus
inhibition method
derivative
deoxynojirimycin
aids
Prior art date
Application number
OA59495A
Other languages
English (en)
French (fr)
Inventor
Dwek Raymond Allen
Fleet George William John
Rademacher Thomas William
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/248,461 external-priority patent/US4849430A/en
Application filed by Monsanto Co filed Critical Monsanto Co
Publication of OA09027A publication Critical patent/OA09027A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
OA59495A 1987-12-21 1988-12-21 Procédé d'inhibition. d'un virus OA09027A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13622487A 1987-12-21 1987-12-21
US16606588A 1988-03-09 1988-03-09
US07/248,461 US4849430A (en) 1988-03-09 1988-09-23 Method of inhibiting virus

Publications (1)

Publication Number Publication Date
OA09027A true OA09027A (fr) 1991-03-31

Family

ID=27384837

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59495A OA09027A (fr) 1987-12-21 1988-12-21 Procédé d'inhibition. d'un virus

Country Status (15)

Country Link
EP (1) EP0324328B1 (de)
JP (1) JPH01203326A (de)
KR (1) KR910010020B1 (de)
AT (1) ATE159427T1 (de)
AU (1) AU605661B2 (de)
CA (1) CA1316459C (de)
DE (1) DE3856052T2 (de)
DK (1) DK175094B1 (de)
ES (1) ES2108680T3 (de)
GR (1) GR3025518T3 (de)
IE (1) IE81173B1 (de)
IL (1) IL88740A (de)
NZ (1) NZ227411A (de)
OA (1) OA09027A (de)
PT (1) PT89266B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA883925B (en) * 1987-06-08 1989-02-22 Merrell Dow Pharma Inhibitors of glycoprotein processing having anti-retroviral activity
US5144037A (en) * 1988-11-03 1992-09-01 G. D. Searle & Co. 1,5-dideoxy-1,5-imino-d-glucitol derivatives
US20030100532A1 (en) 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
EP1030839B1 (de) * 1997-11-10 2004-02-04 G.D. SEARLE & CO. Verwendung von alkylierten iminozuckern zur behandlung von multipler medikamentenresistenz
KR20010040937A (ko) 1998-02-12 2001-05-15 윌리암스 로저 에이 간염 바이러스 감염의 치료를 위한 ｎ-치환된1,5-디데옥시-1,5-이미노-ｄ-글루시톨 화합물의 용도
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
JP2003505501A (ja) 1999-02-12 2003-02-12 ジー・ディー・サール・アンド・カンパニー 肝炎ウィルス感染の処置のためのグルカミン化合物
US6545021B1 (en) 1999-02-12 2003-04-08 G.D. Searle & Co. Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
KR20090040906A (ko) * 2006-08-02 2009-04-27 유나이티드 세러퓨틱스 코오포레이션 바이러스 감염의 리포솜 치료
CN115806913B (zh) * 2022-10-21 2023-09-08 福建省农业科学院植物保护研究所 野尻链霉菌（Streptomyces nojiriensis）菌株9-13及应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
JPS5311800A (en) * 1976-07-20 1978-02-02 Asahi Chemical Ind Method of well preserving and transporting live fish and apparatus therefor
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE3737523A1 (de) * 1987-11-05 1989-05-18 Bayer Ag Verwendung von substituierten hydroxypiperidinen als antivirale mittel

Also Published As

Publication number Publication date
NZ227411A (en) 1997-03-24
KR890009401A (ko) 1989-08-01
ATE159427T1 (de) 1997-11-15
JPH01203326A (ja) 1989-08-16
GR3025518T3 (en) 1998-02-27
CA1316459C (en) 1993-04-20
AU605661B2 (en) 1991-01-17
DK707988D0 (da) 1988-12-20
IE883793L (en) 1989-06-21
EP0324328B1 (de) 1997-10-22
IL88740A (en) 1993-01-31
DK175094B1 (da) 2004-06-01
PT89266A (pt) 1989-12-29
IE81173B1 (en) 2000-05-31
EP0324328A3 (de) 1990-06-20
KR910010020B1 (ko) 1991-12-10
EP0324328A2 (de) 1989-07-19
PT89266B (pt) 1993-11-30
AU2706788A (en) 1989-06-22
DE3856052D1 (de) 1997-11-27
DE3856052T2 (de) 1998-02-19
JPH0521891B2 (de) 1993-03-25
ES2108680T3 (es) 1998-01-01
IL88740A0 (en) 1989-07-31
DK707988A (da) 1989-06-22

Similar Documents

Publication Publication Date Title
NO180407C (no) Anvendelse av 1,3-oksatiolannukleosidanaloger ved fremstilling av et medikament for behandling av hepatitt B
GR3031004T3 (en) HIV protease inhibitors
DK275488A (da) Indolonderivater
ATE142496T1 (de) Verwendung von n-butyl-deoxynojirimycin zur behandlung von herpes
IE930392L (en) Method of treating cachexia and certain new compounds for¹use in this method
OA09027A (fr) Procédé d'inhibition. d'un virus
ZA881726B (en) Method of treating anxiety with tetrahydrobenz(c,d)indole-6-carbozamides
OA08937A (fr) Procédé d'inhibition d'un virus.
DK562488A (da) Farmaceutisk praeparat indeholdende polyminderivater, samt nogle af disse polyaminderivater
PT86859A (pt) Process for the preparation of 9-ethyl-6,9-di-hydro-4,6-dioxo-10-propyl-4h-pyrano]3,2-g"-quinoline-2,8-calcium dicarboxilate and of pharmaceutical compounds containing it
HU9203052D0 (en) Method for treatment of hypertension
DE69619088D1 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
DE3782229D1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE111462T1 (de) 1,4-dihydropyridin-derivate.
EP0447812A3 (en) Use of a dihydropyridine to improve the inner ear blood circulation